Pharmaceutical giants aim to reduce manufacturing turnaround time for personalized blood cancer treatments, potentially benefiting patients at risk of becoming too sick during the process. Notable profits have been generated from these therapies, and quicker manufacturing times could offer a competitive edge and increase treatment uptake.
A new drug, MK-1654, has shown promising results in reducing respiratory syncytial virus infections in infants, bringing hope for preventing severe illness. Learn more about the latest developments in RSV prevention.
Discover how declining birth rates and hospital closures in rural America are reshaping obstetric care and challenging pregnant women in these regions.
Discover the unique therapy involving horses and ponies at the San Giovanni Battista Hospital in Rome, Italy, helping neurological patients restore movements and confidence.
Licensed therapist's untrained spouse impersonates her and provides therapy to hundreds of patients, unraveling a deception that resulted in license surrender and breach notification.